Cardinal Health is significantly bullish heading into fiscal 2014. And for good reason. Not only does the graying of the baby boomers continue to represent a strong tailwind, but there are five other factors that will help fill those sails as well, George Barrett, Cardinal chairman and CEO, told investors Thursday morning.
The National Community Pharmacists Association endorsed the Diabetic Testing Supply Access Act (H.R. 2845), legislation recently introduced by Rep. Peter Welch, D-Vt., that would allow independent community pharmacies to provide same-day delivery services of diabetes testing supplies to Medicare beneficiaries who are homebound, in long-term care or assisted living facilities.
Schake will represent L'Oréal USA for all corporate communications and will lead the external communications strategy in the areas of public and media relations, industry and government relations, sustainability and crisis communications.
The Annals of Internal Medicine published a study comparing generic utilization of common diabetes medications across two government programs — Medicare Part D and the U.S. Department of Veterans Affairs.
Beginning July 1, Walgreens will be able to provide tube feeding services to Medicare patients in 97 of 100 competitive-bidding areas nationwide, the healthcare solutions provider announced last week. The contracts are up for renewal every three years.
This is just another example of how Walgreens is transforming its pharmacy business into a center for healthcare solutions — this goes far beyond dispensing and ultimately aims squarely at reducing hospitalization costs, another way that Walgreens is helping payers bend the cost curve. It begs the question: Should traditional suppliers be thinking about the role their products can play as Walgreens develops new business segments like infusion services?
In April 2003, the U.S. Department of Health and Human Services, or HHS, Office for Civil Rights, or OCR, began enforcing the Health Insurance Portability and Accountability Act, commonly known as HIPAA. Now, a decade later, we can look at how the rule is being applied.
Beginning July 1, Walgreens will serve as a Medicare Contract Supplier by the Centers for Medicare and Medicaid Services to provide services to Medicare beneficiaries requiring enteral nutrition (i.e., tube feeding) in 97 of 100 competitive-bidding areas nationwide, the pharmacy operator recently announced.
Why does the federal government want to block independent pharmacies from providing much-needed diabetes testing supplies to older homebound patients?
In a clear case of over-zealous federal policy-making and glacial government response time, the U.S. Centers for Medicare and Medicaid Services says it will do just that beginning in July. That’s when CMS has decreed it will no longer allow small community pharmacies to deliver diabetic test kits to homebound and long-term-care patients on Medicare.
Several members of Congress are requesting that the Centers for Medicare and Medicaid Services reverse a decision to prohibit independent pharmacies from delivering diabetes-testing supplies to homebound seniors.
Medicare Part D plans that create tiered networks of pharmacies for beneficiaries need more oversight amid reports that small and medium-sized pharmacies are being excluded from them, several senators wrote in a letter last week to the Centers for Medicare and Medicaid Services.
The Marketplace Fairness Act is one step closer to passing. The Senate voted 63-30 to end debate on the bill, which would compel online retailers to collect state taxes, and will make a final decision on the bill on May 6.
“We are writing history, and you are historic figures.” That was a key message that Steve Anderson, National Association of Chain Drug Stores president and CEO, had for community pharmacy during Sunday morning’s business session at NACDS Annual Meeting as the association celebrates its 80th anniversary.
A report released yesterday by the Bipartisan Policy Center, entitled “A Bipartisan Rx for Patient-Centered Care and System-Wide Cost Containment,” contains a smart, forward-looking and no-cost recommendation that could save the government billions, the Generic Pharmaceutical Association said.